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Accumulation of poly(A) RNA in 
nuclear granules enriched in Sam68 
in motor neurons from the SMNΔ7 
mouse model of SMA
J. Oriol Narcís  1, Olga Tapia1, Olga Tarabal2, Lídia Piedrafita2, Jordi Calderó2,  
Maria T. Berciano1,3 & Miguel Lafarga1
Spinal muscular atrophy (SMA) is a severe motor neuron (MN) disease caused by the deletion or 
mutation of the survival motor neuron 1 (SMN1) gene, which results in reduced levels of the SMN protein 
and the selective degeneration of lower MNs. The best-known function of SMN is the biogenesis of 
spliceosomal snRNPs, the major components of the pre-mRNA splicing machinery. Therefore, SMN 
deficiency in SMA leads to widespread splicing abnormalities. We used the SMN∆7 mouse model of 
SMA to investigate the cellular reorganization of polyadenylated mRNAs associated with the splicing 
dysfunction in MNs. We demonstrate that SMN deficiency induced the abnormal nuclear accumulation 
in euchromatin domains of poly(A) RNA granules (PARGs) enriched in the splicing regulator Sam68. 
However, these granules lacked other RNA-binding proteins, such as TDP43, PABPN1, hnRNPA12B, 
REF and Y14, which are essential for mRNA processing and nuclear export. These effects were 
accompanied by changes in the alternative splicing of the Sam68-dependent Bcl-x and Nrnx1 genes, 
as well as changes in the relative accumulation of the intron-containing Chat, Chodl, Myh9 and 
Myh14 mRNAs, which are all important for MN functions. PARG-containing MNs were observed at 
presymptomatic SMA stage, increasing their number during the symptomatic stage. Moreover, the 
massive accumulations of poly(A) RNA granules in MNs was accompanied by the cytoplasmic depletion 
of polyadenylated mRNAs for their translation. We suggest that the SMN-dependent abnormal 
accumulation of polyadenylated mRNAs and Sam68 in PARGs reflects a severe dysfunction of both 
mRNA processing and translation, which could contribute to SMA pathogenesis.
The processing of mRNAs includes three essential modifications, capping, splicing and polyadenylation, which 
mainly occur at the sites of transcription (co-transcriptional)1,2. An analysis of the human transcriptome revealed 
that >90% of protein-coding genes undergo alternative splicing, which generates multiple mRNA variants that 
encode the vast proteomic repertoire required for the protein interactome3. Another fundamental modification of 
most mRNAs is the addition of a polyadenosine tail at the 3′ end. Polyadenylation is a modification necessary not 
only for the stability of mRNAs but also for their nuclear export4. Poly(A)-binding protein nuclear 1 (PABPN1) 
plays a critical role in polyadenylation by strongly enhancing the processivity of poly(A) polymerase4. Upon the 
completion of co-transcriptional processing, mRNAs are exported to the cytoplasm as parts of messenger ribonu-
cleoprotein particles for translation and degradation. During their nuclear journey, mRNAs associate with several 
RNA-binding proteins that contribute to the regulation of their processing and exportation.
On their nuclear route, some normal and incompletely spliced mRNAs are trafficked and may be retained 
in nuclear speckles2,5–7. These nuclear compartments store, assemble and recycle splicing factors and are also 
enriched in poly(A) RNAs and several mRNA processing factors, including PABPN18–11.
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Defects in pre-mRNA splicing or polyadenylation often prevent the recruitment of mRNA export factors, 
resulting in the nuclear retention of immature or aberrant pre-mRNAs12. Thus, some abnormal mRNA tran-
scripts may accumulate in nuclear inclusions under pathological conditions, such as oculopharyngeal muscular 
dystrophy, myotonic dystrophy type 1 and fragile X-associated tremor/ataxia syndrome6,13–15. Moreover, we have 
previously reported that the dysfunction of nuclear RNA processing in the sensory ganglion neurons upon pro-
teasome inhibition induces the nuclear aggregation of polyadenylated mRNAs and the RNA-binding protein 
Sam68 (src-associated protein in mitosis of 68kD) into a new nuclear structure called the “poly(A) RNA granule” 
(PARG)16,17. The sequestration of crucial RNA-binding proteins in nuclear inclusions or granules may prevent 
their normal function, and contribute to disease pathogenesis18.
Spinal muscular atrophy (SMA) is an autosomal recessive disease characterized by the progressive degenera-
tion and loss of spinal cord and brainstem motor neurons (MNs)19,20. SMA is caused by a homozygous deletion 
or mutation in the survival of motor neuron 1 (SMN1) gene that results in decreased levels of the full-length 
SMN protein21,22. SMA patients carry a nearly identical SMN1 gene paralogue named SMN2, which differs from 
SMN1 by a C to T transition in exon 722,23. Although both the SMN1 and SMN2 genes encode the SMN protein, 
approximately 90% of the SMN2 mRNA transcripts generate an alternatively spliced isoform that lacks exon 7 
and encodes a truncated form of the SMN protein (SMN∆7) that is rapidly degraded24. Therefore, SMN2 expres-
sion cannot fully compensate for the deficiency of the full-length SMN protein. The best-known function of 
SMN is the biogenesis of spliceosomal snRNPs (for a review, see25,26). Linked to this function, SMN deficiency in 
SMA produces alterations in this snRNP repertoire and causes widespread splicing defects that result in a severe 
dysregulation of mRNA metabolism in MNs27–31. Splicing alterations in the spinal cord in murine SMA models 
include widespread intron retention, particularly of minor U12 introns, as well as a time-dependent differential 
expression of a number of exons associated with neurodevelopmental and cell stress pathways27–29,31,32. In addi-
tion to the dysfunction of pre-mRNA processing, as a pathogenic factor in SMA, recent studies identified ribo-
some biology and translation efficiency as key processes affected by SMN depletion, which may also contribute to 
MN degeneration and SMA pathogenesis33,34.
The aim of this work is to analyze the subcellular reorganization of polyadenylated mRNAs and certain 
RNA-binding proteins induced by the SMN-dependent dysfunction of pre-mRNA splicing in MNs from the 
SMN∆7 mouse model of SMA. Our results demonstrate the nuclear accumulation of poly(A) RNAs in PARGs 
enriched in the RNA-binding protein Sam68, which is an alternative splicing regulator of pre-mRNAs35–37. The 
formation of PARGs associates with variations in the alternative splicing regulation of several mRNAs, includ-
ing the Sam68-dependent Bcl-x and Nrxn-1 mRNAs. Moreover, the massive accumulation of PARGs in MNs is 
accompanied by cytoplasmic depletion of polyadenylated mRNAs, supporting the existence of a severe dysfunc-
tion of both mRNA processing and translation, which may be an important pathogenic factor in SMA.
Results
Distribution of polyadenylated RNAs in wild-type MN perikarya. With the exception of histone 
mRNAs, all mRNAs are polyadenylated and have a poly(A) tail that is essential for their exportation and stability1,4. 
Therefore, in situ hybridization of poly(A) RNAs with an oligonucleotide poly(dT) probe, which recognizes the 
poly(A) tail, is a good approach for studying the perikaryal distribution of global mRNAs in MNs.
After staining with propidium iodide (PI), a cytochemical fluorescent staining for nucleic acid detection, dis-
sociated MNs from wild-type (WT) mice exhibited a prominent nucleolus and large RNA-rich cytoplasmic areas 
of the Nissl substance, a classic name used to designate the neuronal protein synthesis machinery (for a review, 
see38 (Fig. 1A). Immunolabeling for the TMG-cap and coilin, which are markers of nuclear speckles and Cajal 
bodies, respectively, revealed the organization of these two nuclear compartments involved in mRNA processing. 
As shown in Fig. 1B,C, several nuclear speckles and at least one Cajal body were prominent nuclear structures 
in WT MNs. We next performed fluorescence in situ hybridization for the detection of poly(A) RNAs in disso-
ciated WT MNs. Poly(A) RNAs, in addition to being diffusely distributed throughout the nucleus, excluding the 
nucleolus, were concentrated in nuclear speckles (Fig. 1D,E). As expected, in the cytoplasm, poly(A) RNAs were 
accumulated in the Nissl substance, the main site of mRNA translation (Fig. 1D,E). Triple labeling for poly(A) 
RNA in combination with the TMG-cap and PABPN1, two molecular markers of nuclear speckles, demonstrated 
the accumulation of poly(A) RNAs in these nuclear compartments (Fig. 1E–H), as confirmed by plotting the 
fluorescence intensity profile across a line (Fig. 1I).
Polyadenylated mRNA relocalizes in nuclear poly(A) RNA granules in SMN∆7 MNs. Next, 
we analyzed whether the dysfunction of RNA metabolism in SMN∆7 MNs affects the nuclear and cytoplasmic 
organization of poly(A) RNAs. In situ hybridization revealed an important nuclear reorganization of poly(A) 
RNA in some SMN∆7 MNs during both the late-presymptomatic (postnatal day [P]5) and symptomatic (P14) 
stages, compared with the staining pattern of WT MNs (Figs 1E, 2A–F). There were notable variations in poly(A) 
RNA signal intensity in nuclear speckles and, very remarkably, the de novo formation and accumulation of round 
and sharply defined bodies enriched in poly(A) RNA, which were identified as PARGs16 (Fig. 2B–F).
The PARGs, which ranged from 0.1 to 1.5 µm in diameter, were distributed throughout the nucleus, excluding 
the nucleolus. They frequently appeared in close proximity to the nucleolus and nuclear speckles (Fig. 2B,C,E). 
Two structural configurations of PARGs were found: compact nuclear bodies and ring-shaped structures with 
a poly(A) RNA-rich ring enclosing a hybridization signal-poor central region (Fig. 2C,F). Quantitative analysis 
showed a significant increase in the percentage of SMN∆7 MN-containing PARGs at P14 in comparison to the P5 
(28% vs 17%) (Fig. 2G). Most commonly, the PARG number ranges from a very few to more than 50 per nucleus. 
However, some MNs showed very small, countless, PARGs (Fig. 2F).
Interestingly, MNs harboring a large number of PARGs commonly exhibited a weaker poly(A) RNA hybrid-
ization signal in the cytoplasm (Fig. 2E,F). Moreover, the cytoplasmic accumulation of poly(A) RNAs in stress 
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granules39,40 was not observed in SMN∆7 MNs. Changes in the relative concentration of poly(A) RNA in the 
cytoplasm were validated by a densitometric analysis of the fluorescence hybridization signal intensities at P14. 
Several measurements of the poly(A) RNA signal intensities were performed in the peripheral cytoplasm, where 
the Nissl substance is largely distributed in MNs. A significant reduction of the relative poly(A) RNA concentra-
tion was detected in the Nissl substance of PARG-containing MNs, compared with PARG-free MNs, from both 
SMN∆7 and WT mice (Fig. 2H).
Electron microscopy analysis of PARG-containing MNs revealed structural features of neuronal dysfunction, 
including a paucity of the protein synthesis machinery, nuclear shape aberrations with nuclear envelope invagi-
nations (Fig. 3A) and nucleolar segregation of the granular component (Fig. 3B,C), as we have recently reported34. 
Ultrastructural analysis confirmed the presence of two categories of PARGs: rounded, compact electron-dense 
bodies (Fig. 3A) and larger spherical bodies composed of an electron-dense capsule enclosing an amorphous 
matrix of very low electron density (Fig. 3A, left inset). In addition, PARGs normally appeared to be closely 
surrounded by a layer of perichromatin granules (Fig. 3C, left inset), which are sites of storage for hnRNP com-
plexes41. Importantly, PARGs localized in euchromatin domains, wherein co-transcriptional pre-mRNA pro-
cessing occurs1,2, and they frequently appeared in close proximity to the nucleolus (Fig. 3B) and interchromatin 
granule clusters (Fig. 3A, right inset), the ultrastructural counterpart of nuclear speckles9.
The PARG is a distinct nuclear compartment. To establish the identity of the PARG as a distinct nuclear 
structure in SMA MNs, we performed double labeling for poly(A) RNA in combination with molecular markers 
of nuclear compartments, such as coilin (Cajal bodies), SMN (gems), the TMG-cap (nuclear speckles) and the 
proteasome 20S (clastosomes). In a recent study, we demonstrated that the reduced levels of SMN in MNs from 
SMN∆7 mice were associated with a severe depletion of Cajal bodies34, nuclear structures involved in the bio-
genesis of both spliceosomal snRNPs and nucleolar snoRNPs (for a review, see42,43. Co-staining for poly(A) RNA 
and coilin confirmed the depletion of typical Cajal bodies in SMN∆7 MNs. Nevertheless, small coilin-positive 
Figure 1. Dissociated spinal cord MNs from WT mice at P14. (A) Propidium iodide (PI) staining of the 
nucleolus and Nissl substance. (B) Immunostaining for snRNP splicing factors with the anti-TMG-cap antibody 
shows the typical concentration of splicing factors in nuclear speckles. The samples were counterstained 
with PI. (C) Immunostaining for coilin illustrates a typical Cajal body free in the nucleoplasm. The samples 
were counterstained with PI. (D) FISH for poly(A) RNAs shows a diffuse nuclear pattern, which excludes 
the negative nucleolus, in addition to be concentrated in nuclear speckles. In the cytoplasm, poly(A) RNAs 
accumulate in irregular areas corresponding to the Nissl substance. (E–I) Triple labeling for poly(A) RNAs, the 
TMG-cap and PABPN1, demonstrating the colocalization of these three fluorescent signals in nuclear speckles, 
as revealed by the plot of fluorescence intensity profiles across a line. Scale bar: 5 µm.
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and poly(A) RNA-negative residual Cajal bodies were occasionally found adjacent to PARGs, but as two clearly 
distinct nuclear structures (Fig. 4A). Similarly, gems, SMN-positive and coilin-negative nuclear bodies43,44, were 
never observed in SMN∆7 MNs, and SMN was not concentrated in PARGs (Fig. 4B). Moreover, PARGs did not 
concentrate spliceosomal snRNPs, which typically appeared to be enriched in nuclear speckles immunolabeled 
for the TMG-cap of spliceosomal snRNAs (Fig. 4C). Finally, the catalytic 20S proteasome, a molecular marker of 
clastosomes, which are nuclear bodies enriched in ubiquitylated proteins and active 20S proteasomes45, was not 
concentrated in PARGs (Fig. 4D).
Figure 2. FISH for poly(A) RNAs in WT and SMN∆7 MNs at P5 and P14. (A) Typical distribution of Poly(A) 
RNA concentrated in nuclear speckles and the Nissl substance and diffuse in the nucleoplasm in a WT MN 
at P5. (B,C) Formation of PARGs in SMN∆7 MNs at P5. Note the association of PARGs with the nucleolus 
and nuclear speckles (B,C) and the reduced hybridization signal in the Nissl substance in panel C. (D–F) 
Distribution of poly(A) RNAs in SMN∆7 MNs at P14 showing three progressive stages of PARG accumulation 
in neuronal perikarya. Note the presence of two categories of PARGs, compact (D,E) and ring-shaped (F and 
inset), and the cytoplasmic depletion of poly(A) RNAs in MNs containing a large number of PARGs (E,F). Scale 
bar: 4 µm. (G) Proportion of MNs containing PARGs at P5 and P14. PARGs are already visible at P5 but the 
percentage of MNs containing PARGs notably increases during the late symptomatic stages (P14); p values from 
data comparison of the percentage of PARG-containing MNs: WT vs. SMN∆7 = 3.1E-9 at P5 and 2.7E-8 at P14; 
SMN∆7 P5 vs. SMNΔ7 P14 = 1.5E-4 (***p < 0.0005). (H) Scatter dot plots of the fluorescence intensity signals 
of poly(A) RNAs in the peripheral cytoplasm (Nissl substance) of WT and SMN∆7 MNs at P14. Each dot 
represents the fluorescence signal of poly(A) RNA intensity from a single MN (mean of four measurements). 
The horizontal black line represents the mean for each group normalized to 100% of the WT group. A 
significant reduction in the relative concentration of poly(A) RNAs is observed in PARG-containing SMN∆7 
MNs (n = 93) compared with both WT and SMN∆7 MNs without PARGs (n = 112 and n = 90, respectively). 
p = 4.8E-24 from WT and SMN∆7 data comparison (***p < 0.0005).
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PARGs concentrate the RNA-binding protein Sam68. Since the RNA-binding protein Sam68 is a 
regulator of SMN2 alternative splicing46, we investigated its nuclear reorganization in SMN-deficient MNs from 
the SMN∆7 mice. In WT MNs, co-staining for Sam68 and poly(A) RNA revealed a predominant nuclear local-
ization of Sam68, which excluded the nucleolus and poly(A) RNA-positive nuclear speckles (Fig. 5A–C). The 
nuclear distribution was non-homogeneous, with extensive areas of diffuse staining, and a few irregular domains 
in which higher levels of Sam68 accumulation were observed (Fig. 5B). Although the basic nuclear pattern of 
Sam68 immunostaining was preserved in SMN∆7 MNs, this splicing regulator was strongly concentrated in 
PARGs (Fig. 5D–F). Plot of fluorescence intensity profiles of poly(A) RNA and Sam68 across a line confirmed the 
colocalization of both signals in PARGs from SMN∆7 MNs, as well as the absence of Sam68 in nuclear speck-
les (Fig. 5G,H). Similarly, immunogold electron microscopy for Sam68 showed that both the compact and the 
ring-shaped PARGs were decorated with numerous gold particles (Fig. 5I,J).
We next investigated whether the accumulation of Sam68 in PARGs was associated with changes in Sam68 
mRNA and protein levels in tissue extracts from the spinal cord at P5 and P14. Although we observed a trend 
indicating the downregulation of Sam68 mRNA levels in SMN∆7 mice, this decrease was not significant in the 
qRT-PCR validation (Fig. 5K). Similarly, western blotting analysis revealed no significant changes in Sam68 
Figure 3. Electron micrograph of a PARG-containing MN during the end-stage of disease (P14). (A) The 
cytoplasm is poor in rough endoplasmic reticulum cisterns; note the abnormal nuclear morphology with 
numerous invaginations of the nuclear envelope. The nucleus exhibits two compact PARGs (arrows) and two 
interchromatin granule clusters (IGC). Left inset: detail of a ring-shaped PARGs surrounded by perichromatin 
granules (arrows). Right inset: interchromatin granule cluster with an associated PARG (arrow). Scale bar: 2 µm. 
(B,C) Nucleoli of SMN∆7 MNs at P14, showing the segregation of large masses of the granular component 
(GC), the presence of a nucleolus-attached PARG (arrow in panel B) and a ring-shaped PARG free in the 
nucleoplasm and surrounded by perichromatin granules (arrow in panel C). Scale bar: 1 µm.
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protein levels in samples from SMN∆7 mice compared with those from WT littermates (Fig. 5L). However, as 
expected, a severe reduction of the SMN protein levels was observed in SMN∆7 mice (Fig. 5L).
Previous studies have demonstrated that Sam68 regulates the alternative splicing of two important genes for 
neuronal function, Bcl-x and Nrxn1, which encode an apoptotic regulatory factor and the presynaptic membrane 
protein neurexin, respectively37,47. These studies also suggest that the relocation of Sam68 in nuclear foci affects 
the alternative splicing of its pre-mRNA targets47. This finding prompted us to investigate whether the partial 
Figure 4. (A–D) Double labeling for poly(A) RNAs in combination with molecular markers of Cajal bodies 
(coilin, A), nuclear speckles of splicing factors (TMG-cap, C), gems (SMN, B) and clastosomes (20S proteasome, 
D) demonstrates that the PARG is a distinct nuclear structure. The plot of fluorescence intensity profiles across a 
line clearly demonstrates a lack of concentration of these molecular markers in PARGs. Scale bar: 4 µm.
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Figure 5. (A–H) Representative examples of double labeling for poly(A) RNAs and Sam68 in WT (A–C) 
and SMN∆7 (D–H) MNs at P14. (A–C) In the WT MNs, Sam68 exhibits a diffuse nuclear localization with 
a few areas of higher intensity. (D–F) In the SMN∆7 MN, Sam68, in addition to being diffusely distributed 
throughout the nucleus, appears highly concentrated in two PARGs (F). Note the absence of Sam68 in nuclear 
speckles and the cytoplasmic depletion of poly(A) RNA. Scale bar: 3 µm. (G,H) The plot of the fluorescence 
intensity profiles of poly(A) RNAs and Sam68 across a line confirms the colocalization of both signals in a 
PARG and the concentration of poly(A) RNA, but not of Sam68, in a nuclear speckle. Scale bar: 3 µm. (I,J) 
Representative electron micrographs of immunogold electron microscopy localization of Sam68 in dense 
and ring-shaped PARGs. Scale bar: 200 nm. Insets, FISH detection of poly(A) RNAs in PARGs. (K) qRT-PCR 
of the relative levels of Sam68 mRNA in spinal cord extracts from WT (n = 3) and SMN∆7 mice (n = 5). No 
significant differences (n.s) were found when comparing WT and SMN∆7 samples during both the P5 and P14. 
(L) Representative western blot of Sam68 protein levels showing the dramatic reduction of SMN protein levels 
in spinal cord lysates from SMN∆7 mice, compared with WT mice, and the absence of significant changes in 
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relocation of this splicing regulator in PARGs is associated with changes in the balance of Bcl-x and Nrxn1 splicing 
isoforms. The Bcl-x transcript is alternatively spliced to generate the antiapoptotic Bcl-x(L) or the proapoptotic 
Bcl-x(s) variants48. Real-time PCR quantification of these two variants in spinal cord extracts showed a significant 
decrease of the Bcl-x(s)/Bcl-x(L) ratio in SMN∆7 mice compared with the WT mice (Fig. 5M). Similarly, we found 
a significant reduction of the Nrxn1 4(−)/Nrxn1 4(+) ratio in SMN∆7 mice (Fig. 5M), which reflects a higher rel-
ative abundance of the isoform 4(+), which includes exon 20 in the Nrxn1 alternatively spliced segment 4 (AS4).
PARGs did not concentrate other RNA-binding proteins involved in mRNA processing and 
export. Having demonstrated the concentration of Sam68 in PARGs, we then proceeded to investigate the 
possible accumulation in these granules of other RNA-binding proteins involved in nuclear mRNA processing 
and export, such as PABPN1, TDP43 (TAR DNA-binding protein 43), hnRNP (heterogeneous nuclear ribonu-
cleoprotein) A2/B1, hnRNP M3, Y14 and REF/Aly.
Since PABPN1 binds to the poly(A) tail of polyadenylated RNAs4 and is required for efficient poly(A) RNA 
export from the nucleus49, we investigated changes in its nuclear pattern and protein levels in WT and SMN∆7 
mice. PABPN1 was concentrated in nuclear speckles in both WT and SMN∆7 MNs (Figs 6A, 7B–D), but not in 
PARGs (Fig. 7F), suggesting that PABPN1 is not linked to the poly(A) RNAs within these granules. Moreover, 
western blotting analysis revealed significantly reduced PABPN1 levels in the spinal cord of SMN∆7 mice com-
pared with those of WT animals (Fig. 7E).
TDP43 plays a central role in the pathogenesis of MN diseases50. This protein is a component of the hnRNP 
particles that regulate the splicing of a variety of pre-mRNAs50–52. TDP43 immunolabeling showed a diffuse 
nuclear localization, excluding nuclear speckles and the nucleolus, in both WT and SMN∆7 MNs, but the pro-
tein was not detectable in pathological PARGs (Figs 6B, 7G). Similarly, immunostaining for two hnRNP family 
proteins, A2/B1 and M3/M4, which are involved in packing nascent pre-mRNA and in alternative splicing regu-
lation53,54, revealed their diffuse nuclear distribution in both WT and SMN∆7 MNs (Figs 6C,D, 7H,I). No labeling 
of PARGs was detectable for the A2/B1 and M3/M4 proteins (Fig. 7H,I).
To further investigate the possible concentration of post-spliced mRNA-binding proteins in PARGs, we 
focused on the detection of REF/Aly and Y14, two RNA-binding proteins that are directly implicated in the 
nuclear trafficking and export of mRNAs from the nucleus55,56. REF and Y14 showed a diffuse nuclear local-
ization, which excluded the nucleolus, in addition to being concentrated in nuclear speckles in both WT and 
SMN∆7 MNs (Figs 6E,F, 7J,K). Interestingly, neither export factor was accumulated in pathological PARGs 
(Fig. 7J,K). The lack of colocalization of REF/Aly and Y14 proteins with poly(A) RNA-positive PARGs was con-
firmed by the representation of their fluorescence intensity profiles across a line (Fig. 7F–K).
Accumulation of intron-containing pre-mRNAs encoding essential proteins for MN function 
in the SMN∆7 mice. Previous studies have demonstrated that SMA severity correlates with the decreased 
assembly of spliceosomal snRNP complexes, which leads to widespread defects in the splicing of genes expressed 
in MNs27,29,31. On this basis, we investigated whether the nuclear accumulation of polyadenylated mRNAs in 
PARGs was associated with the splicing dysfunction of four genes, Chat, Chodl, Myh9 and Myh14, which are 
important for MN maturation and synapse development and function28,57. These genes encode choline acetyl-
transferase (Chat) and chondrolectin (Chodl), which are processed by the major U2-dependent spliceosome, 
and the non-muscle myosin II isoforms IIA (Myh9) and IIC (Myh14), which are processed by the minor 
U12-dependent spliceosome. Splicing efficiency was analyzed by estimating the percentage of the unspliced 
(exon-intron sequence) forms of the Chodl, Chat, Myh9 and Myh14 pre-mRNAs by qRT-PCR in spinal cord 
RNA extracts. Importantly, we found that in relation to WT samples, samples from P5 SMNΔ7 animals had a 
significant increase in the proportion of unspliced forms of the Chat and Myh14 mRNAs, while the accumulation 
of the unspliced forms was extended to the four examined pre-mRNAs (Chodl, Chat, Myh9 and Myh14) during 
the late symptomatic stage (P14), (Fig. 8A,B). No significant changes in unspliced Actb (the beta-actin house-
keeping gene) pre-mRNAs were detected when samples from WT and SMN∆7 mice were compared at P5 or P14 
(Fig. 8A,B).
Discussion
The present study demonstrates that the SMN deficiency in SMN∆7 MNs affects the nuclear distribution of pol-
yadenylated mRNAs, resulting in their progressive accumulation in Sam68-positive PARGs. During the sympto-
matic stage, this neuronal response is associated with an increased proportion of intron-containing Chat, Chodl, 
Myh9 and Myh14 mRNAs. The accumulation of poly(A) RNAs in PARGs appears to be an early (P5) cellular man-
ifestation of the nuclear mRNA metabolism dysfunction in SMA MNs, which could contribute to SMA patho-
genesis. Moreover, MNs that contain numerous PARGs frequently exhibit other signs of neuronal dysfunction. 
These signs include the segregation of the granular component of the nucleolus and cytoplasmic reduction of 
polyadenylated mRNAs, which support defective ribosome biogenesis and translation, according to previous 
studies in SMA mice33,34. Collectively, the nuclear accumulation of poly(A) RNAs in PARGs is consistent with the 
splicing alterations reported here and in previous studies in SMA MNs27–29,31.
Sam68 protein levels between WT and SMN∆7 mice at the P14. (M) qRT-PCR of the Bcl-x(s)/Bcl-x(L) and 
Nrxn14(−)/Nrxn1 4(+) mRNA ratios in spinal cord extracts from WT and SMN∆7 mice at P14. A significant 
increase in the relative abundance of the Bcl-x(L) and Nrxn 4(+) splicing variants was detected in the SMN∆7 
mice. p values from WT and SMN∆7 data comparison: 3.3E-4 for Bcl-x(s)/Bcl-x(L) and 4.4E-3 for Nrxn1 4(−)/
Nrxn1 4(+) mRNA ratios (**p < 0.005; ***p < 0.0005).
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A poorly understood aspect of SMA is why MNs that carry the same deletion or mutation of the SMN1 gene 
are affected differently. Our results confirm this heterogeneity, showing that at both P5 and P14, affected MNs 
carrying PARGs coexist with other MNs that have an apparently normal pattern of poly(A) RNA distribution. 
In this regard, differences in the pathogenic vulnerability of MNs have recently been correlated with individual 
differences in SMN protein levels in MNs from a particular SMA mouse58.
Although we have previously reported the presence of PARGs in sensory ganglion neurons upon proteasome 
inhibition16,17, the present work provides the first demonstration that these structures are present in SMA MNs. 
The PARG represents a distinct nuclear entity that is clearly distinguishable by its structure and molecular compo-
sition from other nuclear compartments, such as nuclear speckles9, Cajal bodies43,59,60, gems44 and clastosomes45. 
PARGs share with nuclear speckles the presence of poly(A) RNAs; however, PARGs lack spliceosomal snRNPs 
and display an ultrastructural configuration as sharply defined nuclear bodies that is clearly different from the 
interchromatin granule clusters of nuclear speckles9,43. Cajal bodies, the nuclear structures involved in spliceo-
somal snRNP biogenesis42, are depleted in SMN∆7 MNs34; additionally, the Cajal body marker coilin was not 
detected in PARGs. Similarly, gems, SMN-positive and coilin-negative nuclear bodies of unknown function43,44, 
have been reported in fetal MNs61, but they are absent in postnatal and mature MNs from both WT and SMN∆7 
mice34. Moreover, we did not detect SMN in PARGs. Finally, these RNA granules also lack the 20S proteasome, 
a molecular marker of clastosomes, which are nuclear proteolytic factories enriched in catalytic proteasomes, 
ubiquitylated proteins and proteasome substrates45,62.
PARG-containing MNs were already observed at P5, but they increased in number during the late sympto-
matic stages (P14), presumably reflecting the well-established asynchrony at the beginning of the MN degen-
eration in SMN∆7 mice63. We propose that the formation of PARGs in SMN∆7 MNs reflects a stress-related 
dysfunction of RNA metabolism, essentially in pre-mRNA splicing. Consistent with this view, pre-mRNA splic-
ing has emerged as a well-known and important target of several stressing agents, resulting in alternative splicing 
dysregulation and splicing inhibition64. In the case of SMA, several studies demonstrated that the hyperactivation 
of the endoplasmic reticulum stress pathway and widespread defects in splicing underlie the neurodegeneration 
observed in SMA MNs27,29,31,32,65. Moreover, we have previously reported the formation of PARGs following pro-
teasome inhibition-induced proteotoxic stress in rat sensory ganglion neurons, an experimental condition that 
produces a dysfunction of RNA metabolism and a disruption of the protein synthesis machinery16,17.
An important finding in this study is the accumulation of Sam68 in PARGs. Sam68 is a member of the STAR (sig-
nal transducer and activator of RNA) family of RNA-binding proteins that bind both RNA and DNA and are involved 
in signal transduction, transcription and alternative splicing regulation36,66–68. As a splicing regulator, Sam68 may 
promote exon inclusion or exclusion in certain neural pre-mRNAs, including SMN2, Bcl-x and Nrxn 136,37,47. 
Regarding SMN genes, Sam68 is a physiological regulator of SMN2, but not of SMN1, splicing. Thus, Sam68 
directly binds to the SMN2 pre-mRNA and acts as a splicing repressor of exon 7 inclusion in SMN2 transcripts46,69. 
In the present study, we detected no significant changes in the mRNA and protein levels of Sam68 in the spinal 
cords of SMN∆7 mice compared with the WT animals. Although the accumulation of Sam68 in PARGs should 
reduce its nucleoplasmic levels, potentially facilitating the inclusion of exon 7 in SMN2 transcripts46,69, its partial 
relocation in PARGs does not correct the defective SMN2 splicing in SMN∆7 mice. In fact, SMN protein levels 
Figure 6. (A–F) Double labeling for poly(A) RNAs and the RNA-binding proteins PABPN1 (A), TDP43 (B), 
hnRNP A2/B1 (C), hnRNP M3/M4 (D), REF (E) and Y14 (F) in WT MNs at the P14 stage. Whereas all proteins 
exhibit a nuclear localization, PABPN1 and REF appear concentrated in nuclear speckles. Scale bar: 4 µm.
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Figure 7. (A–D) Double labeling for poly(A) RNA and PABPN1 shows the colocalization of both molecules 
in nuclear speckles in a PARG-free MN from an SMN∆7 mouse. Scale bar: 5 µm. (E) Representative western 
blotting analysis of PABPN1 levels in spinal cord lysates from WT and SMN∆7 mice. Western blot bands for 
PABPN1 were normalized to Tubulin ß-III, which showed double immunoreactive bands at approximately 
70 kDa and 55 kDa. We choose the 55 kDa band for normalization purposes since 50–55 kDa is the predicted 
and apparent molecular weight of Tubulin ß-III in WB analyses. The larger 70 kDa band observed could be due 
to cross-reactivity with a protein related to Tubulin ß-III or a post-translationally modified form of Tubulin 
ß-III. The bars represent a densitometric analysis of the WB bands for PABPN1 normalized to the 55 kDa 
Tubulin ß-III band and expressed as the mean ± SD of three independent experiments (WT (n = 3) vs SMN∆7 
(n = 5)). p value from WT and SMN∆7 data comparison: 4.3E-3 (**p < 0.005). (F–K) Double labeling for 
poly(A) RNAs and the RNA-binding proteins PABPN1 (F), TDP43 (G), hnRNPA2/B1 (H), hnRNPM3/M4 (I), 
REF (J) and Y14 (K) reveals an absence of the colocalization of poly(A) RNA with these RNA-binding proteins 
in PARGs, which was confirmed by plots of their respective fluorescence intensity profiles across a line. Scale 
bar: 4 µm.
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are dramatically reduced in the spinal cords of the SMN∆7 mice during the symptomatic stages (present results 
and34). However, our results show changes in the alternative splicing regulation of the Sam68-dependent Bcl-x 
and Nrxn-1 mRNAs in the spinal cords of SMN∆7 mice. It is well-established that Sam68 binds Bcl-x mRNA, and 
its intracellular levels regulate the balance of alternative splicing to produce pro-apoptotic Bcl-x(s) transcripts or 
anti-apoptotic Bcl-x(L) transcripts48. In particular, whereas the upregulation of Sam68 enhances Bcl-x(s) splicing, 
its downregulation promotes the production of Bcl-x(L) transcripts47. In this context, our finding of a reduction 
of the Bcl-x(s)/Bcl-x(L) ratio in the SMN∆7 mice, compared with WT littermates, is consistent with a downreg-
ulation of Sam68.
Regarding Nrxn1 transcripts, changes in alternative splicing regulation result in a decreased Nrxn1 4(−)/
Nrxn1 4(+) ratio, with a relative increase in the isoform that includes exon 20 in Nrxn1 alternatively spliced 
segment 4 (AS4). Importantly, the neurexin protein 4(+) and 4 (−) variants show different interactomes with 
proteins that are key mediators of synaptic formation and maintenance, including neuroligins (for a review, see37). 
Thus, previous studies have demonstrated that neurexin 4(+) exhibits weak binding with the neuroligin-1B post-
synaptic receptor, which affects synaptic adhesion70,71. In this context, the Sam68-dependent relative abundance 
of neurexin 4(+) in SMN∆7 mice might contribute to the synaptic dysfunction observed in SMA MNs22,25. 
Collectively, our results suggest that the recruitment of Sam68 into PARGs impacts on its normal function in 
splicing regulation. In this line, recent studies have shown that Sam-68 deficient preadipocytes exhibit alter-
native splicing imbalances in components of the mTOR signaling pathway that lead to defective adipogenic 
differentiation72.
The nuclear accumulation of immature or aberrant pre-mRNAs can be triggered by a wide range of errors 
in mRNA processing, which prevent the recruitment of mRNA export factors12. We believe that PARGs may 
Figure 8. (A,B) qRT-PCR determination of the intron-containing (unspliced) Chat, Chodl, Myh9 and Myh14 
pre-mRNAs reveals a significant increase of the relative abundance of their unspliced pre-mRNAs in the spinal 
cords of SMN∆7 mice compared with WT mice at P14 (B). p values from WT and SMN∆7 data comparison 
at P14: 2.1E-3 for Chat, 3,5E-4 for Chodl, 6.3E-4 for Myh9 and 2.2E-4 for Myh14 (**p < 0.005; ***p < 0.0005). 
(A) During the late presymptomatic stage (P5), this increase was only detected in Chodl and Myh9 pre-mRNAs. 
p value from WT and SMN∆7 data comparison at P5: 2,1E-3 for Chodl and 3,5E-4 for Myh9 (**p < 0.005; 
***p < 0.0005). No significant changes (n.s) in unspliced Actb pre-mRNAs were detected when samples from 
WT and SMN∆7 mice were compared at either P5 or P14. The bars represent the mean ± SD of the relative 
fraction of the total RNA transcript that is unspliced pre-mRNA from WT (n = 3) and SMN∆7 mice (n = 5). 
qRT-PCR analyses were always confirmed in triplicate.
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contain incorrectly processed polyadenylated transcripts bound to Sam68, but lack other RNA-binding proteins 
involved in packing nascent mRNA (hnRNPA2/B1), splicing regulation (hnRNPM3/M4 and TDP43) and pol-
yadenylation (PABPN1). Consistent with the nuclear accumulation of poly(A) RNA in PARGs, REF and Y14, two 
RNA-binding proteins that link pre-mRNA splicing to nuclear export73,74, are not detectable in these granules. 
Moreover, we observed a reduction of the levels of PABPN1, a protein that, in addition to polyadenylation, is also 
involved in mRNA export from the nucleus49. Therefore, a deficiency of this export factor in SMN∆7 MNs could 
also contribute to the accumulation of poly(A) RNA in PARGs.
Alternative splicing defects account for nearly 50% of human inherited diseases75, and missplicing events 
are particularly prominent in neurodegenerative diseases76,77. Previous studies in mouse models of SMA have 
demonstrated SMN-dependent downregulated spliceosomal snRNPs and altered alternative splicing, preferen-
tially in U12-dependent introns27–29,31. Our results extend the splicing defects in SMA MNs. Thus, we demonstrate 
here the accumulation of incompletely spliced (intron-containing) Chat, Chodl, Myh9 and Myh14 pre-mRNAs 
during the late symptomatic stage (P14), when a higher incidence of PARG-containing MNs occurs. Interestingly, 
the accumulation of intron-containing mRNAs impacts the transcripts processed by both the minor (Myh9 and 
Myh14) and major (Chat, Chodl) spliceosomes, suggesting a global splicing dysfunction. Importantly, reduced 
Chodl expression has been demonstrated in SMA mouse MNs and linked to MN outgrowth defects28,78.
Although MN functions, such as axonal RNA transport and translation control at the neuromuscular junc-
tion, are altered in SMA79, spliceosome dysfunction plays a critical role in SMA pathogenesis (for a review, see30). 
We propose that the abnormal accumulation of polyadenylated RNAs in PARGs reported here, together with the 
previously demonstrated depletion of canonical (coilin-, SMN- and snRNP-positive) Cajal bodies34,80,81 are two 
cellular manifestations of the global splicing dysfunction in SMA MNs. Notably, an enhancement of the nuclear 
poly(A) RNA signal, which is associated with the formation of cytoplasmic stress granules, has been reported in 
a cellular model of C9orf72 amyotrophic lateral sclerosis82, suggesting that the nuclear accumulation of polyade-
nylated mRNAs may be a more general mechanism in the pathogenesis of MN diseases.
The reduction of the cytoplasmic poly(A) RNA signal in MNs containing a large number of PARGs supports 
a decrease in the translation efficiency, with reduced availability of polyadenylated mRNAs for protein synthesis. 
Consistent with this notion, by ultrastructural and immunocytochemical analyses, we have previously reported 
nucleolar alterations and a severe disruption of the protein synthesis machinery in MNs from the SMN∆7 mice34. 
Furthermore, a recent study on the transcriptome and translatome in SMA mice, by means of next-generation 
sequencing, provides an important catalogue of the mRNAs with altered translation efficiency33. The negative 
impact of the reduced levels of cytoplasmic poly(A) RNAs on translation might be reinforced by the failure of 
SMN∆7 MNs to recruit these RNAs into cytoplasmic stress granules, which is a protective cellular mechanism for 
the transient storage and stabilization of mRNAs during the stress-induced inhibition of translation40.
In conclusion, SMN deficiency in SMN∆7 MNs causes an abnormal nuclear accumulation of polyadenylated 
RNAs in PARGs and the cytoplasmic depletion of these RNAs. This neuronal response suggests a defective mRNA 
processing, export and translation and is also consistent with the widespread splicing defects reported in SMA 
MNs. The present study provides additional support for the hypothesis that the dysfunction of nuclear mRNA 
metabolism plays a critical role in MN degeneration and consequently in SMA pathogenesis.
Material and Methods
Animals. The Smn+/−, SMN2+/+, SMN∆7+/+, heterozygous knockouts for mouse Smn (FVB.
Cg-Tg[SMN2*delta7]4299Ahmb Tg[SMN2]89Ahmb Smn1tm1Msd/J, stock number 005025), which were pur-
chased from The Jackson Laboratory (Sacramento, USA), were crossed to generate Smn−/−, SMN2+/+, SMN∆7+/+ 
(hereafter referred to as SMN∆7) mice and Smn+/+, SMN2+/+, SMN∆7+/+ mice that were wild-type for Smn 
(hereafter referred to as WT). SMN∆7 mice exhibit a severe postnatal SMA phenotype with a mean lifespan 
of approximately two weeks63,83. Animal care and handling were performed in accordance with the Spanish 
legislation (Spanish Royal Decree 53/2013 BOE) and the guidelines of the European Commission for the 
Accommodation and Care of Laboratory Animals (revised in Appendix A of the Council Directive 2010/63/UE). 
The experimental plan was examined and approved by the Ethics Committee of the University of Cantabria and 
the Committee for Animal Care and Use of the University of Lleida. On postnatal day (P) 0, the identification of 
WT and SMN∆7 mice was carried out by genotyping with PCR. DNA was extracted from the tail, as previously 
described63. Age-matched WT littermates of mutant animals were used as controls.
Immunofluorescence and confocal microscopy. For immunofluorescence, four mice per group (WT 
and SMN∆7) at P5 and P14 were perfused, under deep anesthesia with pentobarbital (50 mg/kg), with 3.7% par-
aformaldehyde (freshly prepared) in phosphate-buffered saline (PBS). The spinal cords were rapidly dissected, 
removed, post-fixed for 6 hours and washed in PBS. Transverse sections (160 µm thick) of the spinal cord were 
obtained with a vibratome, and small tissue fragments from the anterior horn were dissected out. The samples 
were transferred to a drop of PBS on a positively charged slide (Superfrost Plus, Thermo Scientific, Germany), and 
squash preparations of dissociated MNs were generated following the previously reported procedure84. The sam-
ples were sequentially treated with 0.5% Triton X-100 in PBS for 45 minutes, 0.1 M glycine in PBS containing 1% 
bovine serum albumin (BSA) for 30 minutes and 0.05% Tween 20 in PBS for 5 minutes. Then, the samples were 
incubated for 3 hours with the primary antibody containing 1% BSA at room temperature, washed with 0.05% 
Tween 20 in PBS, incubated for 45 minutes in the specific secondary antibody conjugated to FITC, TexasRed or 
Cy3, or Cy5 (Jackson, USA) and counterstained with PI for the detection of nucleic acids. The slides were then 
washed in PBS and mounted with the ProLong Anti-Fading Medium (Invitrogen) or Vectashield (Vector, USA).
Confocal images were obtained with an LSM510 (Zeiss, Germany) laser scanning microscope using a 63x 
oil (1.4 NA) objective. To avoid overlapping signals, images were obtained by sequential excitation at 488 nm, 
www.nature.com/scientificreports/
13SCIENTIfIC REPORTS |  (2018) 8:9646  | DOI:10.1038/s41598-018-27821-3
543 nm and 633 nm, to detect FITC, TexasRed or Cy3, and Cy5, respectively. Fluorescence profiles of confocal 
intensity signals across a line were generated to analyze the spatial association between PARGs and the nuclear 
speckles (TMG-Cap), Cajal bodies (coilin), gems (SMN), clastosomes (20S proteasome) and the RNA-binding 
proteins PABPN1, Sam68, TDP43, hnRNP A2/B1, hnRNP M3/M4, REF and Y14. Images were processed using 
Photoshop software.
The following primary antibodies were used for immunofluorescence: the mouse monoclonal antibod-
ies anti-SMN (610646, BD Transduction Laboratories, USA), anti-TMG-cap (NA02A, Oncogene), anti-REF 
(ab6141, Abcam), anti-Y14 (ab5828, Abcam) and anti-hnRNPM3/M4 (ab9548, Abcam), the rabbit polyclonal 
antibodies anti-PABPN1 (sc-67017, Santa Cruz Biotechnology), anti-proteasome 20 S subunit α5 (ab11437, 
Abcam), anti-Sam68 (sc-333, Santa Cruz Biotechnology), anti-coilin 204/10 (204.3 serum85), and anti-TDP43 
(10782-2-AP, Proteintech Inc. Group), and the goat polyclonal antibody anti-hnRNPA2/B1 (sc-10035, Santa Cruz 
Biotechnology).
In situ hybridization and quantification. Tissue fragments from the ventral horn of the spinal cord 
fixed with 3.7% paraformaldehyde were processed for fluorescence in situ hybridization (FISH). MN peri-
karya were then dissociated as described above. Preparations of MNs were permeabilized with TBS-E-SDS for 
15 minutes at 37 °C, washed three times in 6x SSPE-0.1% Tween 20 for 15 minutes, and incubated with the probe 
containing tRNA for 3 hours at 42 °C in a humidified chamber. An oligo dT (50)-mer, 5′-end labeled with biotin 
(MWG-Biotech, Germany) was used as a probe for fluorescence in situ hybridization (FISH) to poly(A) RNA. 
The hybridization mixture contained 80 ng of oligo dT(50), 2xSSC, 1 mg/ml tRNA, 10% dextran sulfate and 25% 
formamide. After hybridization, the MNs were washed in 6xSSC for 15 minutes, and then washed in 4x SSC-
0.1% Tween 20 for 15 minutes at room temperature. The hybridization signal was detected with FITC-avidin for 
30 minutes. For the amplification of the hybridization signal, neuronal samples were incubated with avidin-biotin 
for 30 minutes, washed in 4x SSC-0.1% Tween 20 for 15 minutes and then incubated with FITC-avidin for 30 min-
utes. All samples were mounted with Vectashield (Vector, USA). Some samples were also processed for double- 
or triple-labeling experiments combining poly(A) RNA detection with immunofluorescence for TMG-cap, 
PABPN1, Sam68, TDP43, hnRNP A2/B1, hnRNPM3/M4, REF or Y14.
The quantitative analysis of the proportion of SMN∆7 MNs containing PARGs was performed in squash 
preparations processed for FISH with the poly(dT) probe. The proportion of neurons containing these granules 
was estimated by direct examination of the different focal planes throughout neuronal nuclei, using a 40 × objec-
tive. Quantification was performed on at least 100 MNs from three WT and SMN∆7 mice.
The fluorescence intensity of poly(A) RNAs in the Nissl substance was quantified using the confocal Zeiss LSM 
5 image analysis system. At least 30 confocal images of MNs per animal from WT (n = 3) and SMN∆7 (n = 3) 
mice were recorded using a 63x oil objective. For each MN, four measurements of poly(A) RNA signal intensity in 
the peripheral cytoplasm, where the RNA-rich Nissl substance is largely distributed, were made. The values were 
corrected for background staining by subtraction of a blank measurement taken outside the cell.
Electron microscopy. For conventional ultrastructural examination of MNs, WT and SMN∆7 mice (n = 3 
per group) were perfused under deep anesthesia with 3% glutaraldehyde in 0.1 M phosphate buffer, pH 7.4. 
Transverse sections (500 µm thick) were obtained with a vibratome, and anterior horn tissue fragments were 
dissected out, rinsed in 0.1 M phosphate buffer, postfixed in 2% osmium tetroxide, dehydrated in acetone and 
embedded in araldite (Durcupan, Fluka, Switzerland). Ultrathin sections stained with uranyl acetate and lead 
citrate were examined with a JEOL 201 electron microscope.
For immunoelectron microscopy of Sam68, WT and SMN∆7 mice were perfused with 3.7% paraformalde-
hyde in 0.1 M phosphate buffer. Tissue fragments of the ventral horn were washed in 0.1 M cacodylate buffer, 
dehydrated in increasing concentrations of methanol at −20 °C, embedded in Lowicryl K4M at −20 °C and 
polymerized with ultraviolet irradiation. Ultrathin sections were mounted on nickel grids and sequentially incu-
bated with 0.1 M glycine in PBS for 15 min, 5% BSA in PBS for 30 min and the primary antibody for 2 h at 37 °C. 
After washing, the sections were incubated with the specific secondary antibodies coupled to 10 nm gold particles 
(BioCell, UK; diluted 1:50 in PBS containing 1% BSA). Following immunogold labeling, the grids were stained 
with lead citrate and uranyl acetate and examined with a JEOL 201 electron microscope. As controls, ultrathin 
sections were treated as described above without the primary antibody.
Real time quantitative PCR (qRT-PCR) for relative gene expression analysis. Five SMNΔ7 
(n = 5) and 3 WT (n = 3) mice were used for qRT-PCR studies. The mice were decapitated after being anes-
thetized and the lumbar spinal cord was quickly removed and frozen in liquid nitrogen. RNA was isolated with 
Trizol following the manufacturer’s instructions (Invitrogen, Carlsbad) and purified with the RNeasy kit (Qiagen, 
Hilden, Germany).
One microgram of RNA was reverse-transcribed to first-strand cDNA using a High Capacity cDNA Reverse 
Transcription Kit (Life Technologies) using random hexamers as primers. The cDNA concentration was meas-
ured in a spectrophotometer (Nanodrop Technologies ND-1000) and adjusted to 0.5 μg/μl. The expression of 
the mRNAs candidates Sam68 (Sam68), Actb (ß-actin), Chat (choline O-acetyltransferase), Chodl (chondrolec-
tin), Myh9 (Myosin-9) and Myh14 (Myosin-14), as well as the long and short isoforms of Bcl-x (Bcl-XL and 
Bcl-XS), and Nrxn1 4(−) and Nrxn1 4(+) variants (neurexin 4(+) and neurexin 4(−)) was determined by 
qRT-PCR using gene-specific SYBR Green- based primers (Takara). RT-qPCRs was performed with three bio-
logical replicates and technical triplicates/duplicates of each cDNA sample. The threshold cycle (Ct) for each 
well was determined. The results were normalized to the 45 S ribosomal gene transcripts, which had no sig-
nificant variation in expression across the sample sets and was therefore chosen as a normalizer in our exper-
iments. Relative gene expression was calculated according to the 2−(ΔΔCt) equation86. Each value in this 
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work represents the mean ± SD of independent samples obtained under the same conditions and com-
pared to two replicated qRT-PCR analyses. The SYBR Green-based specific primers for murine RNAs were 
as follows: for the Sam68 mRNA 5′-CTCCAGCTAGGCCAGTGAA-3′ and 5′-TTGTGGGTAAAGCAACAGGA-3′; 
for the unspliced pre-mRNA of Actb containing intron 1, 5′-GACTCCCAGCAC ACTGAACT-3′ and 
5′-CTCAGGGCAGGTGAA ACTGT-3; for the spliced mRNA of Actb 5′-CAGCCTTCCTTCTTGGGTATG-3′ 
and 5′-GGCATAGAGGTCTTT ACGGATG-3′; for the unspliced pre-mRNA of Chat containing intron 3, 
5′-CTTGGGGCCAGTCTGATAGC-3′ and 5′-GGACACATGGCTAGAAGGGG-3′; for the spliced mRNA of 
Chat, 5′-CTGGCTTACTACAGGCTTTACC-3′ and 5′-GTGGCCGATCTGATGTTGT-3′; for the unspliced 
pre-mRNA of Chodl containing intron 3, 5′-GCTGTTGTCTCCCGCATCTT-3′ and 5′-AAGTGGAAG 
CGTTTGGGA TT-3′; for the spliced mRNA of Chodl, 5′-GAAGCAGGCATAATTCCCAATC-3′ and 5′-TTC 
CCAAAGCA ACCAGTATCA-3; for the unspliced pre-mRNA of Myh9 containing intron 6, 5′-CACTTGTGTGGC 
ATTGGGAC-3′ and 5′-AAGAAGGACCT CTCCTCCGA-3′; for the spliced mRNA of Myh9, 5′-TGGTGCCAAC 
ATTGA GACTTAT-3′ and 5′-CCAGACAGCAG GTAGTAGAAGA-3′; for the unspliced pre-mRNA of Myh14 
containing intron 5, 5′-TCACCCTGAAAAGATGCCCC-3′ and 5′-TCGAAGGTCCAGACAGGCAT-3′; for the 
spliced mRNA of Myh14, 5′-GGAGCA AACATCGAGACCTATC-3′ and 5′-GGTAGAAGATATGG 
AAGCTGCATT-3′. For the long form of Bcl-x (Bcl-x(L)), 5′-GAGTTACCGGCGACCCA-3′ and 
5′-CGACAGCAA GCAGGTACAA-3′; for the short form of Bcl-x (Bcl-x(s)), 5′-GCTGCCTACCAGAACCTTATC-
3′and 5′-GGCTCAACCAGTCCATTGT-3′; for the exon 20 containing Nrxn1 variant (Nrxn1 4(+)), 
5′-TAGTTGATGAATGGCTACTCGACAAA-3′ and 5′-GACTCAGTTG TCATAGAGGAAGGCAC-3′; 
for the exon 20 skipped Nrxn1  variant (Nrxn1 4(−)),  5 ′-GCTACCCTGCAGGGCGT-3 ′  and 
5′-GAGGTGGACATCTCAGACTGCAT-3′.
SDS-PAGE and immunoblotting. Spinal cords from WT (n = 3) and SMNΔ7 mice (n = 5) were lysed at 
4 °C in a buffer containing 50 mM Tris (pH 8), 150 mM NaCl, 2% Nonidet P-40, 1 mM MgCl2, 1 mM dithioth-
reitol, and 10% glycerol, and supplemented with EDTA-free complete protease inhibitor cocktail and PhosSTOP 
(Roche). The spinal cord samples were sonicated for 5 cycles of 30 seconds ON/OFF at 4 °C using a Bioruptor 
Plus (Diadode) and left on ice for 20 min. The samples were then cleared by centrifugation at 14,000 rpm for 
10 min at 4 °C. The proteins were separated on 4–20% NuPage TG SDS–PAGE gels (Invitrogen) and trans-
ferred to nitrocellulose membranes using standard procedures. Mouse monoclonal anti-Tubulin ß-III (Sigma 
T8660) and rabbit polyclonal anti-PABPN1 and anti-Sam68 were used. Protein bands were detected with an 
OdysseyTM Infrared-Imaging System (Li-Cor Biosciences) according to the OdysseyTM Western-Blotting 
Protocol. Immunoblots were developed with anti-mouse IRDye800DX or anti-rabbit IRDye680DX (Rockland 
Immunochemicals, USA) secondary antibodies. For the quantitative analysis of the blots, ImageJ software was 
used (U. S. National Institutes of Health, Bethesda, Maryland, USA, http://imagej.nih.gov/ij).
Statistical analysis. For comparisons between WT and SMN∆7 samples, data were analyzed using the 
GraphPad Prism 7 software and an unpaired Student’s t-test. Significance was established at p ≤ 0.05.
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